Lipid Profiling Reveals Different Therapeutic Effects of Metformin and Glipizide in Patients With Type 2 Diabetes and Coronary Artery Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes Care

• Publication date

  2014-09-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc14-0090PMID 25011952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease

  2013cited by this paper
• Response to Comment on Hong et al. Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease. Diabetes Care 2013;36:1304–1311

  2013cited by this paper
• Comment on Hong et al. Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease. Diabetes Care 2013;36:1304–1311

  2013cited by this paper
• Plasma lipid profiling in a large population-based cohort[S]

  2013cited by this paper
• Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach

  2013cited by this paper
• Ultra performance liquid chromatography-tandem mass spectrometry method for profiling of steroid metabolome in human tissue.

  2013cited by this paper
• Sphingomyelin in erythrocyte membranes increases the total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome

  2013cited by this paper
• Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance

  2013cited by this paper
• A practical guide to metabolomic profiling as a discovery tool for human heart disease.

  2013cited by this paper
• Circulating branched‐chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents

  2013cited by this paper
• Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults

  2013cited by this paper
• Plasma Lipid Composition and Risk of Developing Cardiovascular Disease

  2013cited by this paper
• Alternative Markers of Hyperglycemia and Risk of Diabetes

  2012cited by this paper
• Metabolomics and cardiovascular biomarker discovery.

  2012cited by this paper
• Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans

  2012cited by this paper
• The human plasma lipidome.

  2011cited by this paper
• Metabolite profiles and the risk of developing diabetes

  2011cited by this paper
• Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

  2011cited by this paper
• Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

  2011cited by this paper
• The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples.

  2011cited by this paper
• Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)

  2011cited by this paper
• Metabolism and atherogenic disease association of lysophosphatidylcholine.

  2010cited by this paper
• α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population

  2010cited by this paper
• Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population: Multi-Ethnic Study of Atherosclerosis

  2010cited by this paper
• Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients

  2009cited by this paper
• Triacylglycerol Fatty Acid Composition in Diet-Induced Weight Loss in Subjects with Abnormal Glucose Metabolism – the GENOBIN Study

  2008cited by this paper
• RPLC-ion-trap-FTMS method for lipid profiling of plasma: method validation and application to p53 mutant mouse model.

  2008cited by this paper
• Lipid management in patients with diabetes mellitus.

  2005cited by this paper
• Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.

  2005cited by this paper
• UK prospective diabetes study (UKPDS)

  2004cited by this paper
• Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles.

  2004cited by this paper
• Diabetes-related morbidity and mortality in a national sample of U.S. elders.

  2002cited by this paper
• Long-Term Prevention of Bone Loss

  2000cited by this paper
• Pharmacologic Therapy for Type 2 Diabetes Mellitus

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

  1988cited by this paper
• The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.

  1975cited by this paper
• University group diabetes program.

  1971cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper
• Molecular Systems Biology Peer Review Process File Novel Biomarkers for Pre-diabetes Identified by Metabolomics Transaction Report

  year unknowncited by this paper

• Untargeted Metabolomics Identifies N-Lactoyl-Amino Acids as Dose-Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes.

  2026cites this paper
• Identification of specific gut microbes and their therapeutic potential in ameliorating systemic lupus erythematosus in a mouse model.

  2025cites this paper
• Application of lipidomics in the study of traditional Chinese medicine

  2024cites this paper
• Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis

  2024cites this paper
• Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes

  2024cites this paper
• Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs

  2023cites this paper
• Integration of Vitreous Lipidomics and Metabolomics for Comprehensive Understanding of the Pathogenesis of Proliferative Diabetic Retinopathy.

  2023cites this paper
• Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

  2022cites this paper
• Short-Term Treatment of Metformin and Glipizide on Oxidative Stress, Lipid Profile and Renal Function in a Rat Model with Diabetes Mellitus

  2022cites this paper
• Lipids Alterations Associated with Metformin in Healthy Subjects: An Investigation Using Mass Spectrometry Shotgun Approach

  2022influential citation
• Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis

  2021cites this paper
• Why Should Metformin Not Be Given in Advanced Kidney Disease? Potential Leads from Computer Simulations

  2021cites this paper
• Metabolic Profiling Reveals an Abnormal Pattern of Serum Fatty Acids in MRL/lpr Mice Under Treatment With Prednisone

  2020cites this paper
• Diabetes and Stroke: The Role of Glucose Regulation

  2019cites this paper
• Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods

  2019cites this paper
• In vivo pharmacodynamic and pharmacokinetic effects of metformin mediated by the gut microbiota in rats

  2019influential citation
• Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis

  2019cites this paper
• Current and future perspectives of functional metabolomics in disease studies-A review.

  2018cites this paper
• Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment

  2018cites this paper
• Serum Metabolomics Study of Gliclazide-Modified-Release-Treated Type 2 Diabetes Mellitus Patients Using a Gas Chromatography-Mass Spectrometry Method.

  2018cites this paper
• Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals

  2017cites this paper
• The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus

  2017cites this paper
• Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future

  2016cites this paper
• Lipidomic analysis enables prediction of clinical outcomes in burn patients

  2016cites this paper
• Pathways of Acetyl-CoA Metabolism Involved in the Reversal of Palmitate-Induced Glucose Production by Metformin and Salicylate

  2016cites this paper
• Metabolomic Insight into Lipid and Protein Profile in Diabetes Using Mass Spectrometry.

  2016cites this paper
• Mechanism by which Metformin Influence Metabolic Changes in Human:A Systematic-Review

  2016cites this paper
• Effect of metformin on obesity associated metabolic phenotypes

  2016cites this paper
• Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes

  2015cites this paper